Open Payments

LANCE A SLOAN

Type
Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology
Where
LUFKIN, TX
NPI
1588665228
Received
$1,774,173 in 2,776 records, 2019 to 2025 ($1,742,301 general, $31,871 research)
As principal investigator
$1,918,212 of research payments to others in 264 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment384$235,847
2025Research payment7$984
2024General payment449$360,442
2024Research payment1$8,938
2023General payment334$186,189
2023Research payment10$1,955
2022General payment252$127,705
2022Research payment7$3,287
2021General payment324$202,742
2020General payment321$172,406
2019General payment672$456,967
2019Research payment15$16,705

By company

CompanyRecordsAmountYears
AstraZeneca Pharmaceuticals LP613$519,6252019–2025
Lilly USA, LLC526$366,6962019–2025
Corcept Therapeutics218$195,3032019–2025
Boehringer Ingelheim Pharmaceuticals, Inc.239$188,6482019–2025
Janssen Pharmaceuticals, Inc155$134,1212019–2022
PFIZER INC.56$54,4222019–2025
Merck Sharp & Dohme LLC79$46,4392019–2023
GlaxoSmithKline, LLC.34$42,6572022–2024
Eli Lilly and Company40$36,5922019–2025
Bayer Healthcare Pharmaceuticals Inc.81$33,4012020–2025
SANOFI-AVENTIS U.S. LLC45$29,5772019–2025
Novo Nordisk Inc196$28,0902019–2025
Abbott Laboratories37$12,7652021–2025
Janssen Scientific Affairs, LLC18$12,6962019–2024
Rockwell Medical, Inc.16$11,7362019
Novo Nordisk AS12$9,7152022–2024
Ascendis Pharma Endocrinology Inc13$8,2642023–2025
SANOFI US SERVICES INC.14$7,6132019
Boehringer Ingelheim International GmbH13$7,2712019–2022
Travere Therapeutics, Inc.42$6,3022023–2025
Gilead Sciences, Inc.16$4,5712019
IDORSIA PHARMACEUTICALS US INC3$4,2002024–2025
Madrigal Pharmaceuticals9$4,0452025
Amgen Inc.59$2,0802019–2025
Amarin Pharma, Inc.42$8972019–2022
Xeris Pharmaceuticals, Inc.27$7832020–2025
Novartis Pharmaceuticals Corporation19$7082022–2025
Dexcom, Inc.15$6072021–2024
Medtronic, Inc.10$4872021–2025
Radius Health, Inc.17$3242019–2024
Lexicon Pharmaceuticals, Inc.3$3022019–2024
Insulet Corporation12$2552022–2025
Ionis Pharmaceuticals, Inc.2$2412025
Esperion Therapeutics, Inc.6$2022020–2024
Medicure Pharma Inc.1$1992020
Calliditas Therapeutics US Inc.9$1842023–2025
scPharmaceuticals Inc.2$1452024–2025
Horizon Therapeutics plc6$1312020–2023
Otsuka Pharmaceutical Development & Commercialization, Inc.1$1232022
ABBVIE INC.5$1212022–2025
Medtronic MiniMed, Inc.4$1202019–2020
Mylan Inc.1$1192020
Endo Pharmaceuticals Inc.5$802020–2021
RECORDATI_RARE_DISEASES_INC.3$752024–2025
Tandem Diabetes Care, Inc.4$722019–2025
Ardelyx, Inc.1$702025
Genentech USA, Inc.1$662025
Recor Medical Inc2$652025
Ultragenyx Pharmaceutical Inc.4$652020–2022
Kowa Pharmaceuticals America, Inc.3$632020–2022

By nature of payment

NatureRecordsAmount
Compensation for services other than consulting, including serving as faculty or as a speaker at a v559$1,257,206
Travel and Lodging621$208,727
Consulting Fee58$171,902
Food and Beverage1,472$65,054
Research payment40$31,871
Honoraria5$24,335
Compensation for serving as faculty or as a speaker for a medical education program5$9,731
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing1$5,100
Education15$244

Records

DateCompanyAmountNatureFormProductStudyYear
2025-12-30Boehringer Ingelheim Pharmaceuticals, Inc.$334Travel and LodgingIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-12-30Boehringer Ingelheim Pharmaceuticals, Inc.$143Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-12-30Boehringer Ingelheim Pharmaceuticals, Inc.$101Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-12-30Boehringer Ingelheim Pharmaceuticals, Inc.$88Travel and LodgingIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-12-18Calliditas Therapeutics US Inc.$30Food and BeverageIn-kind items and servicesTARPEYO Drug, NEPHROLOGY2025
2025-12-17Corcept Therapeutics$4,000Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKorlym Drug, Endocrinology2025
2025-12-17Corcept Therapeutics$328Travel and LodgingCash or cash equivalentKorlym Drug, Endocrinology2025
2025-12-17Corcept Therapeutics$90Food and BeverageCash or cash equivalentKorlym Drug, Endocrinology2025
2025-12-17Corcept Therapeutics$15Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-12-16CeQur Corporation$16Food and BeverageCash or cash equivalentCeQur Simplicity Device, Diabetes2025
2025-12-09Madrigal Pharmaceuticals$3,430Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentREZDIFFRA Drug, LIVER DISEASE2025
2025-12-09Madrigal Pharmaceuticals$112Travel and LodgingCash or cash equivalentREZDIFFRA Drug, LIVER DISEASE2025
2025-12-09Madrigal Pharmaceuticals$108Food and BeverageIn-kind items and servicesREZDIFFRA Drug, LIVER DISEASE2025
2025-12-09Ascendis Pharma Endocrinology Inc$29Food and BeverageIn-kind items and servicesYorvipath Drug, Endocrinology2025
2025-12-08Boehringer Ingelheim Pharmaceuticals, Inc.$4,275Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2025
2025-12-05Corcept Therapeutics$77Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-12-04Novo Nordisk Inc$52Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2025
2025-12-03Corcept Therapeutics$616Travel and LodgingIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-12-03Corcept Therapeutics$373Travel and LodgingIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-12-03Corcept Therapeutics$368Travel and LodgingIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-12-03Corcept Therapeutics$172Travel and LodgingCash or cash equivalentKorlym Drug, Endocrinology2025
2025-12-03Corcept Therapeutics$137Travel and LodgingCash or cash equivalentKorlym Drug, Endocrinology2025
2025-12-03Corcept Therapeutics$120Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-12-03Corcept Therapeutics$55Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-12-03Corcept Therapeutics$50Food and BeverageCash or cash equivalentKorlym Drug, Endocrinology2025
2025-12-03Corcept Therapeutics$29Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-12-03Corcept Therapeutics$17Food and BeverageCash or cash equivalentKorlym Drug, Endocrinology2025
2025-12-03Travere Therapeutics, Inc.$0EducationIn-kind items and servicesFilspari Drug, Kidney Disease2025
2025-12-02Amgen Inc.$24Food and BeverageIn-kind items and servicesTEPEZZA Biological, Inflammation/Rare Disease2025
2025-11-25Corcept Therapeutics$6,300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKorlym Drug, Endocrinology2025
2025-11-25Corcept Therapeutics$4,300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKorlym Drug, Endocrinology2025
2025-11-25Boehringer Ingelheim Pharmaceuticals, Inc.$4,275Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2025
2025-11-24Boehringer Ingelheim Pharmaceuticals, Inc.$2,137Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2025
2025-11-24Boehringer Ingelheim Pharmaceuticals, Inc.$1,562Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2025
2025-11-24Boehringer Ingelheim Pharmaceuticals, Inc.$1,562Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2025
2025-11-23Ascendis Pharma Endocrinology Inc$74Food and BeverageIn-kind items and servicesYorvipath Drug, Endocrinology2025
2025-11-21Corcept Therapeutics$136Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-11-20Corcept Therapeutics$732Travel and LodgingIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-11-20Corcept Therapeutics$488Travel and LodgingIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-11-20Corcept Therapeutics$467Travel and LodgingIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-11-20Corcept Therapeutics$125Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-11-19Corcept Therapeutics$2,300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKorlym Drug, Endocrinology2025
2025-11-19Bayer Healthcare Pharmaceuticals Inc.$7Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-11-17Madrigal Pharmaceuticals$30Food and BeverageIn-kind items and servicesREZDIFFRA Drug, LIVER DISEASE2025
2025-11-13Corcept Therapeutics$4,300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKorlym Drug, Endocrinology2025
2025-11-13Bayer Healthcare Pharmaceuticals Inc.$13Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-11-13Bayer Healthcare Pharmaceuticals Inc.$1Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-11-12Novo Nordisk Inc$37Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2025
2025-11-11Travere Therapeutics, Inc.$13Food and BeverageIn-kind items and services2025
2025-11-11Travere Therapeutics, Inc.$0EducationIn-kind items and servicesFilspari Drug, Kidney Disease2025
2025-11-10Corcept Therapeutics$24Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-11-09AstraZeneca Pharmaceuticals LP$59Food and BeverageIn-kind items and services2025
2025-11-08Genentech USA, Inc.$66Food and BeverageIn-kind items and servicesGazyva Biological, BioOncology2025
2025-11-07Travere Therapeutics, Inc.$72Food and BeverageIn-kind items and services2025
2025-11-07Recor Medical Inc$47Food and BeverageCash or cash equivalentParadise Ultrasound Renal Denervation System Device, Devices2025
2025-11-06Travere Therapeutics, Inc.$124Food and BeverageIn-kind items and servicesFilspari Drug, Kidney Disease2025
2025-11-05Boehringer Ingelheim Pharmaceuticals, Inc.$227Travel and LodgingIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-11-05Boehringer Ingelheim Pharmaceuticals, Inc.$117Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-11-05BETA BIONICS, INC.$13Food and BeverageIn-kind items and servicesiLet Bionic Pancreas Device, Automated insulin delivery system2025
2025-11-04Boehringer Ingelheim Pharmaceuticals, Inc.$413Travel and LodgingIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-11-04Boehringer Ingelheim Pharmaceuticals, Inc.$117Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-10-29Corcept Therapeutics$519Travel and LodgingCash or cash equivalentKorlym Drug, Endocrinology2025
2025-10-29Corcept Therapeutics$359Travel and LodgingCash or cash equivalentKorlym Drug, Endocrinology2025
2025-10-29Corcept Therapeutics$304Food and BeverageCash or cash equivalentKorlym Drug, Endocrinology2025
2025-10-29Corcept Therapeutics$215Travel and LodgingCash or cash equivalentKorlym Drug, Endocrinology2025
2025-10-29Corcept Therapeutics$80Food and BeverageCash or cash equivalentKorlym Drug, Endocrinology2025
2025-10-29RECORDATI_RARE_DISEASES_INC.$32Food and BeverageIn-kind items and servicesISTURISA Drug, ENDOCRINE AGENT2025
2025-10-29Novo Nordisk Inc$9Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2025
2025-10-28Ascensia Diabetes Care Us Inc.$43Food and BeverageIn-kind items and services2025
2025-10-27Travere Therapeutics, Inc.$0EducationIn-kind items and servicesFilspari Drug, Kidney Disease2025
2025-10-24Travere Therapeutics, Inc.$418Travel and LodgingIn-kind items and services2025
2025-10-23Lilly USA, LLC$73Food and BeverageCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-10-23Lilly USA, LLC$11Food and BeverageCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-10-22Corcept Therapeutics$2,800HonorariaCash or cash equivalentKorlym Drug, Endocrinology2025
2025-10-21PFIZER INC.$4Food and BeverageIn-kind items and servicesNGENLA Drug, ENDOCRINE DISEASE;METABOLIC DISEASE2025
2025-10-17Lilly USA, LLC$1,140Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-10-15Corcept Therapeutics$241Travel and LodgingCash or cash equivalentKorlym Drug, Endocrinology2025
2025-10-15Corcept Therapeutics$55Food and BeverageCash or cash equivalentKorlym Drug, Endocrinology2025
2025-10-15Travere Therapeutics, Inc.$1EducationIn-kind items and servicesFilspari Drug, Kidney Disease2025
2025-10-13Novartis Pharmaceuticals Corporation$15Food and BeverageIn-kind items and servicesLEQVIO Drug, Cardiology/Vascular Diseases2025
2025-10-11Travere Therapeutics, Inc.$240Travel and LodgingIn-kind items and services2025
2025-10-11Travere Therapeutics, Inc.$240Travel and LodgingIn-kind items and services2025
2025-10-11Travere Therapeutics, Inc.$149Food and BeverageIn-kind items and services2025
2025-10-11Travere Therapeutics, Inc.$73Food and BeverageIn-kind items and services2025
2025-10-11Travere Therapeutics, Inc.$49Food and BeverageIn-kind items and services2025
2025-10-11Travere Therapeutics, Inc.$45Food and BeverageIn-kind items and services2025
2025-10-11Travere Therapeutics, Inc.$34Food and BeverageIn-kind items and services2025
2025-10-09Lilly USA, LLC$2,280Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-10-09Lilly USA, LLC$1,995Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-10-09PFIZER INC.$1,450Consulting FeeCash or cash equivalentPREVNAR 20 Biological, VACCINES2025
2025-10-08PFIZER INC.$906Consulting FeeCash or cash equivalentPREVNAR 20 Biological, VACCINES2025
2025-10-08Bayer Healthcare Pharmaceuticals Inc.$176Travel and LodgingIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-10-08Bayer Healthcare Pharmaceuticals Inc.$101Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-10-08Boehringer Ingelheim Pharmaceuticals, Inc.$78Travel and LodgingIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-10-08Boehringer Ingelheim Pharmaceuticals, Inc.$27Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-10-08Bayer Healthcare Pharmaceuticals Inc.$27Travel and LodgingIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-10-08Bayer Healthcare Pharmaceuticals Inc.$16Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-10-07Tandem Diabetes Care, Inc.$19Food and BeverageIn-kind items and servicest:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2025
2025-10-06Eli Lilly and Company$180Food and BeverageCash or cash equivalent2025
2025-10-06Eli Lilly and Company$178Food and BeverageCash or cash equivalent2025
2025-10-06Insulet Corporation$26Food and BeverageCash or cash equivalentOmnipod Device, Insulin Pump2025
2025-10-04Bayer Healthcare Pharmaceuticals Inc.$258Travel and LodgingIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-10-04Bayer Healthcare Pharmaceuticals Inc.$66Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-10-02Lilly USA, LLC$512Travel and LodgingIn-kind items and services2025
2025-10-02Lilly USA, LLC$502Travel and LodgingIn-kind items and services2025
2025-10-02Lilly USA, LLC$417Travel and LodgingIn-kind items and services2025
2025-10-02Lilly USA, LLC$353Travel and LodgingIn-kind items and services2025
2025-10-02Lilly USA, LLC$197Travel and LodgingIn-kind items and services2025
2025-10-01Corcept Therapeutics$6,300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKorlym Drug, Endocrinology2025
2025-10-01Corcept Therapeutics$4,300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKorlym Drug, Endocrinology2025
2025-10-01Corcept Therapeutics$3,500Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKorlym Drug, Endocrinology2025
2025-10-01Corcept Therapeutics$3,500Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKorlym Drug, Endocrinology2025
2025-10-01Novo Nordisk Inc$1,965Consulting FeeCash or cash equivalentOzempic Drug, Diabetes2025
2025-10-01Novo Nordisk Inc$655Consulting FeeCash or cash equivalentOzempic Drug, Diabetes2025
2025-10-01Novo Nordisk Inc$24Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2025
2025-09-30Medtronic, Inc.$103Food and BeverageIn-kind items and servicesMINIMED 780G Device, Durable Pump2025
2025-09-27Bayer Healthcare Pharmaceuticals Inc.$5,585Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKerendia Drug, Cardio-Renal2025
2025-09-27Corcept Therapeutics$75Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-27Corcept Therapeutics$49Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-27Corcept Therapeutics$48Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-27Corcept Therapeutics$26Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-27Corcept Therapeutics$26Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-26Corcept Therapeutics$690Travel and LodgingIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-26Corcept Therapeutics$408Travel and LodgingIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-25Corcept Therapeutics$151Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-25Corcept Therapeutics$52Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-25Corcept Therapeutics$35Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-24Corcept Therapeutics$7,000HonorariaCash or cash equivalentKorlym Drug, Endocrinology2025
2025-09-24Corcept Therapeutics$2,300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKorlym Drug, Endocrinology2025
2025-09-24Corcept Therapeutics$711Travel and LodgingIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-24Corcept Therapeutics$162Travel and LodgingIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-24Corcept Therapeutics$124Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-24Corcept Therapeutics$22Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-23Novo Nordisk Inc$8Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2025
2025-09-18Lilly USA, LLC$148Travel and LodgingCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-09-18Lilly USA, LLC$97Travel and LodgingCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-09-18Lilly USA, LLC$37Food and BeverageCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-09-18Lilly USA, LLC$33Food and BeverageCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-09-18Lilly USA, LLC$29Travel and LodgingCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-09-17Corcept Therapeutics$6,300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKorlym Drug, Endocrinology2025
2025-09-16Lilly USA, LLC$1,140Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-09-15Corcept Therapeutics$29Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-12Lilly USA, LLC$1,140Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-09-11Corcept Therapeutics$536Travel and LodgingIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-11Corcept Therapeutics$344Travel and LodgingIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-09-11Bayer Healthcare Pharmaceuticals Inc.$95Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-09-11Madrigal Pharmaceuticals$18Food and BeverageIn-kind items and servicesREZDIFFRA Drug, LIVER DISEASE2025
2025-09-08Boehringer Ingelheim Pharmaceuticals, Inc.$4,275Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2025
2025-09-08Amgen Inc.$15Food and BeverageIn-kind items and servicesEVENITY Biological, Bone Health2025
2025-09-08Insulet Corporation$11Food and BeverageCash or cash equivalentOmnipod Device, Insulin Pump2025
2025-09-03Novo Nordisk Inc$9Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2025
2025-09-03PFIZER INC.$5Food and BeverageIn-kind items and servicesNGENLA Drug, ENDOCRINE DISEASE;METABOLIC DISEASE2025
2025-09-02Amgen Inc.$19Food and BeverageIn-kind items and servicesTEPEZZA Biological, Inflammation/Rare Disease2025
2025-09-02Globus Medical, Inc.$17Food and BeverageCash or cash equivalentSenza Device, SPINAL CORD STIMULATOR2025
2025-08-26Lilly USA, LLC$1,250Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-08-25Lilly USA, LLC$2,280Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-08-25Lilly USA, LLC$1,995Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-08-21Lilly USA, LLC$436Travel and LodgingIn-kind items and services2025
2025-08-21Lilly USA, LLC$426Travel and LodgingIn-kind items and services2025
2025-08-21Lilly USA, LLC$95Food and BeverageCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-08-20Corcept Therapeutics$2,300Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentKorlym Drug, Endocrinology2025
2025-08-20Corcept Therapeutics$1,155HonorariaCash or cash equivalentKorlym Drug, Endocrinology2025
2025-08-20Ascendis Pharma Endocrinology Inc$22Food and BeverageIn-kind items and servicesYorvipath Drug, Endocrinology2025
2025-08-20Bayer Healthcare Pharmaceuticals Inc.$20Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-08-19Amgen Inc.$26Food and BeverageIn-kind items and services2025
2025-08-19Novo Nordisk Inc$11Food and BeverageIn-kind items and servicesRybelsus Drug, Diabetes2025
2025-08-17Bayer Healthcare Pharmaceuticals Inc.$275Travel and LodgingIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-08-17Bayer Healthcare Pharmaceuticals Inc.$161Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-08-17Bayer Healthcare Pharmaceuticals Inc.$115Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-08-17Bayer Healthcare Pharmaceuticals Inc.$48Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-08-15Lilly USA, LLC$1,140Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, Diabetes2025
2025-08-13Lilly USA, LLC$18Food and BeverageIn-kind items and servicesMOUNJARO Drug, Diabetes2025
2025-08-12Boehringer Ingelheim Pharmaceuticals, Inc.$1,140Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2025
2025-08-12Boehringer Ingelheim Pharmaceuticals, Inc.$1,140Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2025
2025-08-12Novo Nordisk Inc$20Food and BeverageIn-kind items and servicesWegovy Drug, Obesity2025
2025-08-06Bayer Healthcare Pharmaceuticals Inc.$17Food and BeverageIn-kind items and servicesKerendia Drug, Cardio-Renal2025
2025-08-05Corcept Therapeutics$25Food and BeverageIn-kind items and servicesKorlym Drug, Endocrinology2025
2025-08-05Novo Nordisk Inc$6Food and BeverageIn-kind items and servicesOzempic Drug, Diabetes2025
2025-08-02Ionis Pharmaceuticals, Inc.$91Food and BeverageIn-kind items and services2025
2025-07-30RECORDATI_RARE_DISEASES_INC.$19Food and BeverageIn-kind items and servicesISTURISA Drug, ENDOCRINE AGENT2025
2025-07-30Boehringer Ingelheim Pharmaceuticals, Inc.$15Food and BeverageIn-kind items and servicesJARDIANCE Drug, DIABETES2025
2025-07-28Insulet Corporation$23Food and BeverageCash or cash equivalentOmnipod Device, Insulin Pump2025
2025-07-24Boehringer Ingelheim Pharmaceuticals, Inc.$4,275Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2025
2025-07-24Boehringer Ingelheim Pharmaceuticals, Inc.$4,275Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2025
2025-07-24Boehringer Ingelheim Pharmaceuticals, Inc.$2,137Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalentJARDIANCE Drug, DIABETES2025
2025-07-24Lilly USA, LLC$147Travel and LodgingCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-07-24Lilly USA, LLC$44Travel and LodgingCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-07-24Lilly USA, LLC$27Food and BeverageCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-07-24Lilly USA, LLC$21Travel and LodgingCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-07-23Lilly USA, LLC$43Travel and LodgingCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-07-23Lilly USA, LLC$27Food and BeverageCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-07-23Novartis Pharmaceuticals Corporation$21Food and BeverageIn-kind items and servicesFabhalta Drug, Immunology2025
2025-07-22Novo Nordisk Inc$19Food and BeverageIn-kind items and servicesRybelsus Drug, Diabetes2025
2025-07-21AstraZeneca Pharmaceuticals LP$16Food and BeverageIn-kind items and servicesFARXIGA Drug, Cardiovascular and Metabolism2025
2025-07-17Lilly USA, LLC$60Travel and LodgingCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-07-17Lilly USA, LLC$42Travel and LodgingCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-07-17Lilly USA, LLC$14Food and BeverageCash or cash equivalentZEPBOUND Drug, Obesity2025
2025-07-17Amgen Inc.$7Food and BeverageIn-kind items and servicesEVENITY Biological, Bone Health2025
2025-07-16Xeris Pharmaceuticals, Inc.$16Food and BeverageIn-kind items and servicesGVOKE HYPOPEN Drug, Diabetes2025
2025-07-14Madrigal Pharmaceuticals$120Food and BeverageIn-kind items and servicesREZDIFFRA Drug, LIVER DISEASE2025

The latest 200 records of 2,776.

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2025-12-17Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$10,020A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-11-30Boehringer Ingelheim Pharma GmbH & Co.KGTexas Institute For Kidney And Endocrine Disorders$40,061A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-11-17Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$5,065A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-10-22Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$14,645A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-09-30Boehringer Ingelheim Pharma GmbH & Co.KGTexas Institute For Kidney And Endocrine Disorders$40,061A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-09-08Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$17,905A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-08-31Boehringer Ingelheim Pharma GmbH & Co.KGTexas Institute For Kidney And Endocrine Disorders$40,061A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-08-18Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$6,360A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-07-07Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$13,435A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-06-09Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$26,960A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-05-12Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$8,170A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-04-30Boehringer Ingelheim Pharma GmbH & Co.KGTexas Institute For Kidney And Endocrine Disorders$13,353A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-04-09Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$15,290A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-03-12Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$17,670A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-02-25Eli Lilly and CompanyLANCE SLOAN,$289A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF TIRZEPATIDE ON THE REDUCTION 2025
2025-02-21Amgen Inc.Texas Institute For Kidney And Endocrine Disorders$31,904A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiova2025
2025-02-14Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$6,540A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2025-01-21Eli Lilly and CompanyLANCE SLOAN,$41,105A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON 2025
2025-01-21Eli Lilly and CompanyLANCE SLOAN,$24,677A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF TIRZEPATIDE ON THE REDUCTION 2025
2025-01-13Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$9,810A multicenter, international, randomized, double-blind, placebo-controlled clinical trial of the aldosterone synthase in2025
2024-09-30Boehringer Ingelheim Pharma GmbH & Co.KGTexas Institute For Kidney And Endocrine Disorders$78,073Phase III Renal Outcomes2024
2024-07-23Eli Lilly and CompanyLANCE SLOAN,$29,302A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON 2024
2024-07-03Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$45,175Phase III Renal Outcomes2024
2024-06-25Amgen Inc.Texas Institute For Kidney And Endocrine Disorders$2,80220170625_VESALIUS - CV2024
2024-05-10Eli Lilly and CompanyLANCE SLOAN,$198A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON 2024
2024-01-25Eli Lilly and CompanyLANCE SLOAN,$240A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF TIRZEPATIDE ON THE REDUCTION 2024
2024-01-10Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$14,700EMPA-KIDNEY2024
2024-01-08Amgen Inc.Texas Institute For Kidney And Endocrine Disorders$27,01420170625_VESALIUS - CV2024
2024-01-02Eli Lilly and CompanyLANCE SLOAN,$30,456A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF TIRZEPATIDE ON THE REDUCTION 2024
2023-10-17SANOFI US SERVICES INC.Texas Institute For Kidney And Endocrine Disorders$1,250A 24-Week, Multicenter, Randomized, Open-Label, Parallel-Group Trial Comparing the Efficacy and Safety of Insulin Glargi2023
2023-09-12SANOFI US SERVICES INC.Texas Institute For Kidney And Endocrine Disorders$1,500A 24-Week, Multicenter, Randomized, Open-Label, Parallel-Group Trial Comparing the Efficacy and Safety of Insulin Glargi2023
2023-07-13SANOFI US SERVICES INC.Texas Institute For Kidney And Endocrine Disorders$4,250A 24-Week, Multicenter, Randomized, Open-Label, Parallel-Group Trial Comparing the Efficacy and Safety of Insulin Glargi2023
2023-06-26GlaxoSmithKline, LLC.Texas Institute For Kidney And Endocrine Disorders$127A PHASE 3 RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, PARALLEL-GROUP,2023
2023-05-23Boehringer Ingelheim Pharmaceuticals, Inc.Texas Institute For Kidney And Endocrine Disorders$8,381BI 685509 Dose finding PoCC in DKD2023
2023-04-17Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$8,900EMPA KIDNEY2023
2023-04-04Eli Lilly and CompanyLANCE SLOAN$62,031A PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF TIRZEPATIDE ON THE REDUCTION OF 2023
2023-03-10Janssen Research & Development, LLCTEXAS INSTITUTE FOR KIDNEY AND ENDO CRINE DISORDERS$1,955A Randomized Multi Center Double Blind Parallel Group Placebo Controlled Study to Investigate the Efficacy and Safety of2023
2023-02-06Amgen Inc.TEXAS INST FOR KIDNEY & ENDOCRINE DISORDERS$13,95520170625_VESALIUS - CV2023
2023-01-10Eli Lilly and CompanyLANCE SLOAN$604A PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF TIRZEPATIDE ON THE REDUCTION OF 2023
2022-11-17Eli Lilly and CompanyUPSTATE MEDICAL UNIVERSITY$562A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF TIRZEPATIDE ON THE REDUCTION 2022
2022-11-08Janssen Research & Development, LLCTEXAS INSTITUTE FOR KIDNEY AND ENDO CRINE DISORDERS$6,562A Randomized Multi Center Double Blind Parallel Group Placebo Controlled Study to Investigate the Efficacy and Safety of2022
2022-11-01Eli Lilly and CompanyLANCE SLOAN,$456A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF TIRZEPATIDE ON THE REDUCTION 2022
2022-10-31Janssen Research & Development, LLCTEXAS INSTITUTE FOR KIDNEY AND ENDO CRINE DISORDERS$6,116A Randomized Multi Center Double Blind Parallel Group Placebo Controlled Study to Investigate the Efficacy and Safety of2022
2022-09-26Janssen Research & Development, LLCTEXAS INSTITUTE FOR KIDNEY AND ENDO CRINE DISORDERS$2,585A Randomized Multi Center Double Blind Parallel Group Placebo Controlled Study to Investigate the Efficacy and Safety of2022
2022-09-08Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$2BI 685509 Dose finding PoCC in Non Diabetic CKD2022
2022-05-25Janssen Research & Development, LLCTEXAS INSTITUTE FOR KIDNEY AND ENDO CRINE DISORDERS$13,577A Randomized Multi Center Double Blind Parallel Group Placebo Controlled Study to Investigate the Efficacy and Safety of2022
2022-04-19Janssen Research & Development, LLCTEXAS INSTITUTE FOR KIDNEY AND ENDO CRINE DISORDERS$3,362A Randomized Multi Center Double Blind Parallel Group Placebo Controlled Study to Investigate the Efficacy and Safety of2022
2022-03-22GlaxoSmithKline, LLC.LANCE SLOAN MD AND ENDOCRINE DISORDERS$453A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P2022
2022-03-22GlaxoSmithKline, LLC.LANCE SLOAN MD AND ENDOCRINE DISORDERS$707A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P2022
2022-03-22GlaxoSmithKline, LLC.LANCE SLOAN MD AND ENDOCRINE DISORDERS$10,641A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P2022
2022-03-22GlaxoSmithKline, LLC.LANCE SLOAN MD AND ENDOCRINE DISORDERS$324A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P2022
2022-03-21Janssen Research & Development, LLCTEXAS INSTITUTE FOR KIDNEY AND ENDO CRINE DISORDERS$1,935A Randomized Multi Center Double Blind Parallel Group Placebo Controlled Study to Investigate the Efficacy and Safety of2022
2022-03-03GlaxoSmithKline, LLC.LANCE SLOAN MD AND ENDOCRINE DISORDERS$1,000A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P2022
2022-03-03GlaxoSmithKline, LLC.LANCE SLOAN MD AND ENDOCRINE DISORDERS$12,001A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P2022
2022-03-02GlaxoSmithKline, LLC.LANCE SLOAN MD AND ENDOCRINE DISORDERS$360A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P2022
2022-02-15Amgen Inc.Texas Institute For Kidney And Endocrine Disorders$7,14320170625_VESALIUS - CV2022
2022-02-03Boehringer Ingelheim Pharmaceuticals, Inc.Texas Institute For Kidney And Endocrine Disorders$37,253BI 685509 Dose finding PoCC in DKD2022
2022-01-31Boehringer Ingelheim Pharma GmbH & Co.KGTexas Institute For Kidney And Endocrine Disorders$30,497EMPA KIDNEY2022
2022-01-26Boehringer Ingelheim Pharma GmbH & Co.KGTexas Institute For Kidney And Endocrine Disorders$1,498BI 685509 Dose finding PoCC in DKD2022
2022-01-24Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$34,805EMPA KIDNEY2022
2022-01-22Amgen Inc.Texas Institute For Kidney And Endocrine Disorders$1,40120170625_VESALIUS - CV2022
2022-01-20Boehringer Ingelheim Pharmaceuticals, Inc.Texas Institute For Kidney And Endocrine Disorders$5,100BI 685509 Dose finding PoCC in Non Diabetic CKD2022
2021-12-31Merck Sharp & Dohme LLCTexas Institute For Kidney And Endocrine Disorders$664A Randomized Parallel-group, Placebo-controlled, Double-blind, Event-driven, Multi-center Phase 2 Clinical Outcome Trial2021
2021-12-31Merck Sharp & Dohme LLCTexas Institute For Kidney And Endocrine Disorders$32,620A Randomized Parallel-group, Placebo-controlled, Double-blind, Event-driven, Multi-center Phase 2 Clinical Outcome Trial2021
2021-12-22Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$3,275EMPA-KIDNEY2021
2021-12-16Boehringer Ingelheim Pharma GmbH & Co.KGTexas Institute For Kidney And Endocrine Disorders$3BI 685509 Dose finding/PoCC in DKD2021
2021-12-01GlaxoSmithKline, LLC.SLOAN LANCE A OFFICE$318A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P2021
2021-12-01GlaxoSmithKline, LLC.SLOAN LANCE A OFFICE$2,485A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P2021
2021-11-30Boehringer Ingelheim Pharma GmbH & Co.KGTexas Institute For Kidney And Endocrine Disorders$12,198EMPA-KIDNEY2021
2021-11-29Janssen Research & Development, LLCTEXAS INSTITUTE FOR KIDNEY AND ENDO CRINE DISORDERS$6,993A Randomized Multi Center Double Blind Parallel Group Placebo Controlled Study to Investigate the Efficacy and Safety of2021
2021-11-19Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$4,585EMPA-KIDNEY2021
2021-11-18Boehringer Ingelheim Pharma GmbH & Co.KGTexas Institute For Kidney And Endocrine Disorders$1,366BI 685509 Dose finding/PoCC in DKD2021
2021-10-31Amgen Inc.Texas Institute For Kidney And Endocrine Disorders$275(GOULD): a Registry of High Cardiovascular Risk Subjects in the United States2021
2021-10-27Boehringer Ingelheim International GmbHTexas Institute For Kidney And Endocrine Disorders$3,930EMPA-KIDNEY2021
2021-10-26Boehringer Ingelheim LimitedTexas Institute For Kidney And Endocrine Disorders$425BI 685509 Dose finding/PoCC in Non-Diabetic CKD2021
2021-10-26Boehringer Ingelheim Pharma GmbH & Co.KGTexas Institute For Kidney And Endocrine Disorders$33BI 685509 Dose finding/PoCC in DKD2021
2021-10-15Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$4EX6018-47582021
2021-10-15Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$7EX6018-47582021
2021-10-15Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$11EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$75EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$9EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$14EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021
2021-10-11Novo Nordisk ASTexas Institute For Kidney And Endocrine Disorders$2EX6018-47582021

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Angelina CountyLufkin city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Lufkin, TX, county Angelina County, TX, state Texas; placed by its city name.

MeasurePlace (city or town)
Lufkin, TX
County
Angelina County, TX
State
Texas
Population B0100334,25187,27530,188,424
Population, 2020 census P134,14386,39529,145,505
Median age B0100234.637.835.6
Under 18 B0100127.2%25.3%25.0%
65 and over B0100115.2%16.9%13.4%
Households B1100112,91232,27110,992,816
Foreign born B0500212.6%8.0%17.6%
Median household income B19013$57,048$60,960$78,476
Median family income B19113$72,115$74,557$94,599
Per capita income B19301$28,636$29,614$40,752
Poverty rate B1700118.0%15.8%13.8%
Unemployment rate B230257.0%6.4%5.3%
Civilian labor force B2302515,65739,76415,233,563
Mean commute (minutes) B0801317.220.926.7
Bachelor's degree or higher B1500321.8%17.9%33.8%
Housing units B2500114,55537,02312,128,515
Owner-occupied B2500351.6%64.0%62.6%
Renters B2500348.4%36.0%37.4%
Median home value B25077$179,600$163,500$283,800
Median gross rent B25064$1,079$1,076$1,403
White, not Hispanic B0300242.4%58.2%39.1%
Black B0300218.3%12.1%11.9%
Hispanic or Latino B0300233.8%23.5%39.7%
Asian B030021.8%0.9%5.5%
American Indian and Alaska Native B030020.1%0.3%0.1%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Lufkin, TX.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.